David John Nutt,Hannah Thurgur
David John Nutt
Anne Katrin Schlag,David J Nutt,Michael T Lynskey
Anne Katrin Schlag
Clinical pharmacology [0.03%]
临床药理学
Severin B Vogt,Matthias E Liechti
Severin B Vogt
To design therapeutic trials and select the most appropriate substance and dose for an indication, a detailed understanding of clinical pharmacology is crucial. In recent years, several studies have explored the human pharmacology of differ...
Dasha Anderson,Emma S J Robinson
Dasha Anderson
In recent years, public and academic interest into psychedelics has increased, given the clinical evidence of their potential benefits for treating psychiatric conditions such as major depressive disorder (MDD). While this has been accompan...
Serotonin, immune function, and psychedelics as potent anti-inflammatories [0.03%]
血清素，免疫功能和迷幻药的强效抗炎作用
Charles D Nichols,Timothy P Foster
Charles D Nichols
Psychedelics are primarily recognized for their profound behavioral effects, leading most research on psychedelics and their primary target, the 5-HT2A receptor, to focus on brain activity. However, these receptors are not only found within...
Ede Frecska,Attila Kovács,Attila Szabo
Ede Frecska
This paper explores the therapeutic potential of DMT in neuroprotective strategies, particularly concerning ischemia-reperfusion injury (IRI) and neurodegenerative disorders. Besides its potent serotonin receptor actions, DMT is also an end...
Psychedelics for the treatment of end-of-life distress in patients with a life-threatening disease [0.03%]
psychedelics在生命终期病患的末期焦虑治疗中的应用
Stephan Tap,Tijmen Bostoen,Joost Breeksema et al.
Stephan Tap et al.
Patients with a life-threatening disease (LTD) sometimes suffer from end-of-life distress (EOLD) which refers to the physical, psychological, emotional, and spiritual suffering related to chronic illness and the possibility of death. Pallia...
Tijmen Bostoen,Stephan Tap,Joost Breeksema et al.
Tijmen Bostoen et al.
Post-Traumatic Stress Disorder (PTSD) is a severe psychiatric condition that develops after exposure to trauma such as combat, natural disasters, or assault. It is characterized by re-experiencing trauma, avoidance, hyperarousal, and negati...
Caitlin M DuPont,Matthew W Johnson
Caitlin M DuPont
The current chapter presents the literature evaluating the effects of classic psychedelic treatments on five substance use disorders: alcohol, tobacco, opioid, stimulant, and cannabis. Most work on psychedelics and substance use disorders w...
David E Nichols,Charles D Nichols
David E Nichols
Classic psychedelics have been used by various cultures for millennia for healing and religious purposes. The modern era of psychedelic science began with the first empirical experiments by Dr. Arthur Heffter in 1898 to determine just what ...